首页> 外文会议>ASME Bioengineering Conference >BIOMOLECULE-IMPREGNATED NANOCOMPOSITE WITH SPATIOTEMPORAL CONTROL OVER RELEASE AND DEGRADATION KINETIC FOR VASCULAR ENGINEERING
【24h】

BIOMOLECULE-IMPREGNATED NANOCOMPOSITE WITH SPATIOTEMPORAL CONTROL OVER RELEASE AND DEGRADATION KINETIC FOR VASCULAR ENGINEERING

机译:生物重度浸渍纳米复合材料,具有时尚控制过度释放和降解动力学用于血管工程

获取原文

摘要

Autologous vessels are the gold standard for small-diameter (<6 mm) vascular bypass; however, many patients lack suitable autologous tissues due to diseases or prior vein harvest. As an alternative, synthetic vascular grafts made from bioinert synthetic materials such as polytetrafluoroethylene (PTFE) are currently used in the medical field. The high long-term failure rate of these materials in the replacement of small vessels is known to be associated with the lack of proper signalling events by PTFE to vascular cells causing adverse hemodynamic, inflammatory or coagulatory conditions. Therefore, constant and pressing is the demand for a more biocompatible conduit with structure and function similar to native vessels. For this reason, bioresorbable scaffold constructs which can provide not only proper mechanical support, but also precise molecular cues, are desired (1). In particular, proper degradation kinetics and molecule release profiles are needed to facilitate remodeling and integration process in vivo over the time for long-term patency (2). Mesenchymal stem cells (MSC) have been proposed as a promising approach to tissue regeneration and repair, in combination with a scaffold and bioactive growth factors. In the case of vascular tissue engineering, due to the MSC differentiation plasticity, cell differentiation may be guided to a specific type, for example endothelial cells (EC) or smooth muscle cells (SMC), to help the formation of biomimetic vascular tissues (3). To facilitate biomimetic repair and regeneration, it is crucial to achieve temporal and spatial control over the delivery of specific growth factors to MSC.
机译:自体血管是小直径(<6mm)血管旁路的金标准;然而,由于疾病或先前的静脉收获,许多患者缺乏合适的自体组织。作为替代方案,如聚四氟乙烯(PTFE)从生物惰性合成材料制成的合成血管移植物在医疗领域中目前使用。已知这些材料在更换小血管中的高长期失效率与PTFE缺乏适当的信号事件与导致不良血液动力学,炎症或凝固条件的血管细胞相关联。因此,恒定和压制是对具有与本地容器类似的结构和功能的更生物相容性导管的需求。因此,期望可以提供不仅可以提供适当的机械支撑,而且精确的分子提示的生物可吸收支架构建体(1)。特别地,需要适当的降解动力学和分子释放曲线,以便在长期通畅(2)中的时间内体内重塑和整合过程。间质干细胞(MSC)已被提出作为使用的支架和生物活性的生长因子有希望的方法来组织再生和修复,混合使用。在血管组织工程中,由于MSC分化可塑性的情况下,细胞的分化可被引导到一个特定的类型,例如内皮细胞(EC)或平滑肌细胞(SMC),以帮助仿生血管组织的形成(3 )。为了促进仿生修复和再生,对在将特定生长因子交付给MSC的情况下实现时间和空间控制至关重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号